research use only
Cat.No.S6070
| Related Targets | CFTR CRM1 CD markers AChR Calcium Channel Sodium Channel Potassium Channel GABA Receptor ATPase GluR |
|---|---|
| Other TRP Channel Inhibitors | SKF96365 2-APB (2-Aminoethyl Diphenylborinate) AMG-517 GSK2193874 GSK1016790A HC-030031 Capsazepine EIPA (L593754) HC-067047 SB705498 |
|
In vitro |
DMSO
: 68 mg/mL
(199.9 mM)
Ethanol : 5 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 340.16 | Formula | C15H11Cl2NO4 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 351424-20-9 | -- | Storage of Stock Solutions |
|
|
| Synonyms | Compound 5, TRPM4 inhibitor 5 | Smiles | OC(=O)C1=C(NC(=O)COC2=CC=CC=C2Cl)C=C(Cl)C=C1 | ||
| Targets/IC50/Ki |
TRPM4
1.5µM
|
References |
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06026280 | Recruiting | Job Stress|Distress Emotional |
Inspiration at Work|Northwestern University |
August 7 2023 | Not Applicable |
| NCT05364138 | Recruiting | Breast Cancer|Benign Breast Disease|Cervix Cancer |
Brigham and Women''s Hospital|Partners in Health|Rwanda Biomedical Centre|Johns Hopkins University |
July 31 2023 | -- |
| NCT05862038 | Recruiting | Atrial Fibrillation |
Ana Jordan|University Hospital Dubrava |
February 10 2023 | -- |
| NCT05414890 | Recruiting | NMO Spectrum Disorder|NMDA-R Encephalitis|Diagnostic Self Evaluation|Immune System Diseases|Nervous System Diseases|Autoimmune Diseases of the Nervous System|Autoimmune Diseases |
Beijing Tiantan Hospital|Tianjin Medical University General Hospital |
June 30 2022 | -- |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.